News from regado biosciences, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-SMALL:APRI)

Nov 11, 2009, 09:00 ET

Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris...

Nov 10, 2009, 09:00 ET

Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen...

Nov 03, 2009, 09:24 ET

Regado Biosciences to Present at the 3rd Annual Canaccord Adams Cardiovascular Conference on November 10, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Oct 27, 2009, 08:30 ET

Regado Biosciences to Present at the BIO-Europe Conference 2009 on November 3, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Oct 22, 2009, 09:41 ET

Regado Biosciences to Present at the 8th Annual BIO Investor Forum on October 29, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today Ellen...

Oct 05, 2009, 08:30 ET

Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today...

Sep 17, 2009, 20:54 ET

Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Sep 15, 2009, 08:30 ET

Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Sep 09, 2009, 08:30 ET

Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System

Regado Biosciences, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced...

Sep 04, 2009, 08:30 ET

Regado Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2009 on September 11, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Sep 03, 2009, 08:30 ET

Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Aug 31, 2009, 08:30 ET

Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that...

Aug 24, 2009, 08:30 ET

Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System

Regado Biosciences, Inc, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents,...

Jul 20, 2009, 08:30 ET

Regado Biosciences Expands Medical Advisory Board

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents,...

Jun 02, 2009, 08:30 ET

Regado Biosciences Establishes Medical Advisory Board

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today...

Mar 30, 2009, 11:09 ET

Regado Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference

Regado Biosciences today announced that the Company's Chief Executive Officer, David J. Mazzo, Ph.D., will be presenting at the upcoming 16th...

Feb 12, 2009, 08:30 ET

Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference

Regado Biosciences, Inc. announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 2009 Wharton...

Jan 15, 2009, 08:30 ET

Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer

Regado Biosciences, Inc., announced today the appointment of Steven L. Zelenkofske, D.O., F.A.C.C. to the position of Senior Vice President,...

Jan 06, 2009, 12:27 ET

Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference

Regado Biosciences, Inc. announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 27th Annual...

Dec 02, 2008, 07:30 ET

Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer

Regado Biosciences, Inc., announced today the appointment of Ellen McDonald to the newly created position of Senior Vice President of Business...